The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Lexaria Bioscience Corp shares valued at $67,175 were purchased by CHRISTOPHER RICHARD on Dec 03 ’24. At $2.47 per share, CHRISTOPHER RICHARD acquired 27,172 shares. The insider’s holdings grew to 50,000 shares worth approximately $69000.0 following the completion of this transaction.
Also, CHRISTOPHER RICHARD purchased 22,828 shares, netting a total of over 51,217 in proceeds. Following the buying of shares at $2.24 each, the insider now holds 22,828 shares.
Before that, TURKEL CATHERINE C. had added 1,600 shares to its account. In a trade valued at $5,008, the Director bought Lexaria Bioscience Corp shares for $3.13 each. Upon closing the transaction, the insider’s holdings increased to 1,600 shares, worth approximately $4278.0.
Analyzing LEXX Stock Performance
During the last five days, there has been a surge of approximately 2.99%. Over the course of the year, Lexaria Bioscience Corp shares have dropped approximately -34.29%. Shares of the company reached a 52-week high of $2.4300 on 01/06/25 and a 52-week low of $1.1500 on 03/04/25. A 50-day SMA is recorded $1.5127, while a 200-day SMA reached $2.3935.
Support And Resistance Levels for Lexaria Bioscience Corp (LEXX)
According to the 24-hour chart, there is a support level at 1.3203, which, if violated, would cause prices to drop to 1.2607. In the upper region, resistance lies at 1.4598. The next price resistance is at 1.5397. RSI (Relative Strength Index) is 42.36 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0538, which suggests the price will decrease in the coming days. Percent R is at 78.72%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
